[Q fever with endocarditis: clinical presentation and serologic follow-up of 21 patients].

PubWeight™: 0.77‹?›

🔗 View Article (PMID 9592893)

Published in Schweiz Med Wochenschr on April 04, 1998

Authors

C Duroux-Vouilloz1, G Praz, P Francioli, O Péter

Author Affiliations

1: Institut Central des Hôpitaux Valaisans, Sion.

Articles citing this

Q fever endocarditis: a case report and review of the literature. Can J Cardiol (2006) 0.94

Articles by these authors

Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study. BMJ (1997) 6.01

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet (2000) 5.49

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study. Lancet (1999) 4.83

Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect Immun (1995) 3.65

AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study. JAMA (1999) 3.34

HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load. JAMA (2001) 2.95

Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study. AIDS (2002) 2.90

Erythema chronicum migrans--a tickborne spirochetosis. Acta Trop (1983) 2.85

Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors. Clin Infect Dis (1994) 2.61

Leukopenia and thrombocytopenia in a patient with early Lyme borreliosis. Clin Infect Dis (1996) 2.49

Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer. A randomized controlled trial. Ann Intern Med (1994) 2.45

Successful single-dose amoxicillin prophylaxis against experimental streptococcal endocarditis: evidence for two mechanisms of protection. J Infect Dis (1983) 2.35

Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med (1999) 2.35

Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study. Clin Infect Dis (2001) 2.24

An important outbreak of human Q fever in a Swiss Alpine valley. Int J Epidemiol (1987) 2.21

Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study. Lancet (2001) 2.01

Expression of Staphylococcus aureus clumping factor A in Lactococcus lactis subsp. cremoris using a new shuttle vector. Infect Immun (2000) 1.97

Influence of bacille Calmette-Guérin vaccination on size of tuberculin skin test reaction: to what size? Clin Infect Dis (2004) 1.94

Evaluation of three chromogenic media (MRSA-ID, MRSA-Select and CHROMagar MRSA) and ORSAB for surveillance cultures of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect (2006) 1.89

Immunoglobulin responses in acute Q fever. J Clin Microbiol (1985) 1.80

[Clinical aspects observed during an epidemic of 415 cases of Q fever]. Schweiz Med Wochenschr (1985) 1.69

Typing of Pneumocystis carinii f. sp. hominis by single-strand conformation polymorphism of four genomic regions. J Clin Microbiol (1997) 1.59

Molecular epidemiology of methicillin-resistant Staphylococcus aureus at a low-incidence hospital over a 4-year period. Infect Control Hosp Epidemiol (1995) 1.59

Water disinfection with ozone, copper and silver ions, and temperature increase to control Legionella: seven years of experience in a university teaching hospital. J Hosp Infect (2005) 1.56

Evaluation of the complement fixation and indirect immunofluorescence tests in the early diagnosis of primary Q fever. Eur J Clin Microbiol (1985) 1.55

Double-locus sequence typing using clfB and spa, a fast and simple method for epidemiological typing of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2006) 1.54

Clinical significance of Candida isolated from peritoneum in surgical patients. Lancet (1989) 1.53

Confirmation that Rickettsia helvetica sp. nov. is a distinct species of the spotted fever group of rickettsiae. Int J Syst Bacteriol (1993) 1.53

Bacteremia due to viridans streptococci in neutropenic patients: a review. Am J Med (1994) 1.53

Transmission of Pneumocystis carinii from AIDS patients to other immunosuppressed patients: a cluster of Pneumocystis carinii pneumonia in renal transplant recipients. AIDS (1991) 1.52

Comparison of enzyme-linked immunosorbent assay and complement fixation and indirect fluorescent-antibody tests for detection of Coxiella burnetii antibody. J Clin Microbiol (1987) 1.44

Role of amoxicillin serum levels for successful prophylaxis of experimental endocarditis due to tolerant streptococci. J Infect Dis (1994) 1.40

Epidemiological validation of pulsed-field gel electrophoresis patterns for methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2001) 1.39

Ribotyping of Pseudomonas aeruginosa: discriminatory power and usefulness as a tool for epidemiological studies. J Clin Microbiol (1993) 1.38

Routine diagnosis of Borrelia burgdorferi (sensu lato) infections using a real-time PCR assay. Clin Microbiol Infect (2001) 1.36

Seroprevalence of Q-fever in febrile individuals in Mali. Trop Med Int Health (2005) 1.36

Unusual spread of a penicillin-susceptible methicillin-resistant Staphylococcus aureus clone in a geographic area of low incidence. Clin Infect Dis (1999) 1.36

Campylobacter fetus subspecies fetus bacteremia. Arch Intern Med (1985) 1.35

Methicillin-resistant Staphylococcus aureus: phylogenetic relatedness between European epidemic clones and Swiss sporadic strains. Microb Drug Resist (2000) 1.34

Typing methods to approach Pneumocystis carinii genetic heterogeneity. FEMS Immunol Med Microbiol (1998) 1.32

Prevalence and risk factors for nosocomial infections in four university hospitals in Switzerland. Infect Control Hosp Epidemiol (1999) 1.32

Bacterial brain abscesses: factors influencing mortality and sequelae. Clin Infect Dis (1992) 1.29

Mechanisms of successful amoxicillin prophylaxis of experimental endocarditis due to Streptococcus intermedius. J Infect Dis (1986) 1.26

Scored antibody reactivity determined by immunoblotting shows an association between clinical manifestations and presence of Borrelia burgdorferi sensu stricto, B. garinii, B. afzelii, and B. Valaisiana in humans. J Clin Microbiol (1999) 1.25

Changing molecular epidemiology of methicillin-resistant Staphylococcus aureus in a small geographic area over an eight-year period. J Clin Microbiol (2007) 1.24

Successful prophylaxis of experimental streptococcal endocarditis with single-dose amoxicillin administered after bacterial challenge. J Infect Dis (1990) 1.23

Evidence for clonal evolution among highly polymorphic genes in methicillin-resistant Staphylococcus aureus. J Bacteriol (2006) 1.21

Typing of Pneumocystis carinii f. sp. hominis by PCR-SSCP to indicate a high frequency of co-infections. J Med Microbiol (2000) 1.21

Study of Staphylococcus aureus pathogenic genes by transfer and expression in the less virulent organism Streptococcus gordonii. Infect Immun (2001) 1.18

Contribution of clumping factor B to pathogenesis of experimental endocarditis due to Staphylococcus aureus. Infect Immun (2000) 1.18

Preemptive treatment approach to cytomegalovirus (CMV) infection in solid organ transplant patients: relationship between compliance with the guidelines and prevention of CMV morbidity. Transpl Infect Dis (2000) 1.16

Simulation of amoxicillin pharmacokinetics in humans for the prevention of streptococcal endocarditis in rats. Antimicrob Agents Chemother (1994) 1.16

Genetic diversity of Pneumocystis carinii in HIV-positive and -negative patients as revealed by PCR-SSCP typing. AIDS (2001) 1.16

Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis. Antimicrob Agents Chemother (1998) 1.15

Carriage of Pneumocystis carinii by immunosuppressed patients and molecular typing of the organisms. AIDS (2000) 1.12

Discrepancies between MBC and actual killing of viridans group streptococci by cell-wall-active antibiotics. Antimicrob Agents Chemother (1986) 1.10

Vancomycin prophylaxis of experimental Streptococcus sanguis. Inhibition of bacterial adherence rather than bacterial killing. J Clin Invest (1981) 1.10

Imported epidemic typhus. Lancet (1998) 1.10

Poor value of pulsed-field gel electrophoresis to investigate long-term scale epidemiology of methicillin-resistant Staphylococcus aureus. Infect Genet Evol (2002) 1.08

Simple method for rapid diagnosis of catheter-associated infection by direct acridine orange staining of catheter tips. J Clin Microbiol (1988) 1.06

Usefulness of procalcitonin serum level for the diagnosis of bacteremia. Eur J Clin Microbiol Infect Dis (2001) 1.05

Community-acquired pneumonia. A prospective outpatient study. Medicine (Baltimore) (2001) 1.04

Haemodynamics in phaeochromocytoma. A report of 2 cases. Intensive Care Med (1979) 1.03

Quantitative antibiogram typing using inhibition zone diameters compared with ribotyping for epidemiological typing of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (1994) 1.01

Long term vascular complications of Coxiella burnetii infection in Switzerland: cohort study. BMJ (1999) 1.01

Reemergence of gentamicin-susceptible strains of methicillin-resistant Staphylococcus aureus in France: a phylogenetic approach. J Clin Microbiol (2001) 1.01

Usefulness of double locus sequence typing (DLST) for regional and international epidemiological surveillance of methicilin-resistant Staphylococcus aureus. Clin Microbiol Infect (2009) 1.00

Simulated human serum profiles of one daily dose of ceftriaxone plus netilmicin in treatment of experimental streptococcal endocarditis. Antimicrob Agents Chemother (1993) 0.98

Vector competence of Ixodes scapularis and Ixodes ricinus (Acari: Ixodidae) for three genospecies of Borrelia burgdorferi. J Med Entomol (1998) 0.98

Phagocytosis and killing of Neisseria gonorrhoeae by Trichomonas vaginalis. J Infect Dis (1983) 0.98

Outbreak of Salmonella braenderup gastroenteritis due to contaminated meat pies: clinical and molecular epidemiology. Clin Microbiol Infect (2000) 0.98

Faucets as a reservoir of endemic Pseudomonas aeruginosa colonization/infections in intensive care units. Intensive Care Med (2004) 0.98

Determination of the copy number of the nuclear rDNA and beta-tubulin genes of Pneumocystis carinii f. sp. hominis using PCR multicompetitors. J Eukaryot Microbiol (2001) 0.97

Successful prophylaxis against experimental streptococcal endocarditis with bacteriostatic antibiotics. J Infect Dis (1982) 0.97

Once-weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients. Clin Infect Dis (1995) 0.96

Clinical epidemiology and research on HIV infection in Switzerland: the Swiss HIV Cohort Study 1988-2000. Schweiz Med Wochenschr (2000) 0.95

The impact of penicillinase on cefamandole treatment and prophylaxis of experimental endocarditis due to methicillin-resistant Staphylococcus aureus. J Infect Dis (1998) 0.95

Serological diagnosis of Q fever endocarditis. Eur Heart J (1986) 0.95

Molecular epidemiology of predominant clones and sporadic strains of methicillin resistant Staphylococcus aureus in Switzerland and comparison with European epidemic clones. Clin Microbiol Infect (2002) 0.95

Progress and problems in the fight against AIDS. N Engl J Med (1998) 0.92

Quantitative antibiogram as a typing method for the prospective epidemiological surveillance and control of MRSA: comparison with molecular typing. Infect Control Hosp Epidemiol (1996) 0.92

Molecular Epidemiology of Pseudomonas aeruginosa in the Intensive Care Units - A Review. Open Microbiol J (2007) 0.91

Prophylaxis failure is associated with a specific Pneumocystis carinii genotype. Clin Infect Dis (2001) 0.91

Relevance of animal models to the prophylaxis of infective endocarditis. J Antimicrob Chemother (1987) 0.91

[Seroprevalence of human Q fever in Switzerland]. Schweiz Med Wochenschr (1986) 0.91

Vancomycin serum levels and toxicity in chronic hemodialysis patients with Staphylococcus aureus bacteremia. Clin Nephrol (1983) 0.91

Risk of Borrelia burgdorferi infection in western Switzerland following a tick bite. Eur J Clin Microbiol Infect Dis (2004) 0.90

Matrix metalloproteinases in the cerebrospinal fluid of patients with Lyme neuroborreliosis. J Infect Dis (1998) 0.90

Importance of genotypic and phenotypic tolerance in the treatment of experimental endocarditis due to Streptococcus gordonii. J Infect Dis (1997) 0.90

Development of a molecular typing method for Pneumocystis carinii sp.f. hominis. J Eukaryot Microbiol (1996) 0.88

Successful prophylaxis of experimental streptococcal endocarditis with single doses of sublethal concentrations of penicillin. J Antimicrob Chemother (1985) 0.88

Tick zoonoses in the southern part of Switzerland (Canton Ticino): occurrence of Borrelia burgdorferi sensu lato and Rickettsia sp. Eur J Epidemiol (1997) 0.88

The occurrence of percutaneous injuries to health care workers: a cross sectional survey in seven Swiss hospitals. Schweiz Med Wochenschr (1998) 0.88

Comparison of single doses of amoxicillin or of amoxicillin-gentamicin for the prevention of endocarditis caused by Streptococcus faecalis and by viridans streptococci. J Infect Dis (1985) 0.88

[Diagnostic of Pneumocystis jirovecii pneumonia in a non HIV patient]. Rev Med Suisse (2010) 0.88

Dapsone/pyrimethamine may prevent mycobacterial disease in immunosuppressed patients infected with the human immunodeficiency virus. Clin Infect Dis (1995) 0.87

Nosocomial infections in Swiss university hospitals: a multi-centre survey and review of the published experience. Swiss-Noso Network. Schweiz Med Wochenschr (1999) 0.87

Impact of standardised review of intravenous antibiotic therapy 72 hours after prescription in two internal medicine wards. J Hosp Infect (2009) 0.85